Cytopharma

Cytopharma is a leading pharmaceutical company dedicated to the manufacturing and marketing of generic cytotoxic drugs. With a strong commitment to patient care, Cytopharma focuses on providing high-quality, affordable oncology medicine to cancer patients worldwide, supporting them in their fight against the disease.

Established in Tunisia since 2011, Cytopharma boasts a state-of-the-art production line for injectable oncology products in both liquid and lyophilized forms. The company’s steadily growing product portfolio includes essential molecules such as Fluorouracil (5-FU), Oxaliplatin, Epirubicin, Paclitaxel, and Docetaxel. Cytopharma is expanding its reach across Africa, the Middle East, and Europe. Cytopharma is open to various partnerships, including distribution, contract manufacturing, co-promotion, and co-marketing.

Strategically located at Z.I. Hammam Zriba 4, Zaghouan, 1152, TN, Cytopharma is positioned for continued growth and innovation in the pharmaceutical sector. Discover how Cytopharma can help you achieve your business objectives through collaboration and high-quality products. We invite the manager of Cytopharma to create a customized and exclusive company showcase and product listing on our platform.